|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01526 RICI HEALTH
Nominal 
0.870 +0.030 (+3.571%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | 6.309% | 6.262% | 7.905% | 6.389% | 4.151% |
| ROAE (%) | 20.531% | 24.047% | 34.967% | 35.649% | 30.686% |
| Return on Capital Employed (%) | 9.970% | 10.367% | 14.714% | 12.051% | 7.244% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 43.189% | 39.931% | 41.752% | 39.040% | 35.871% |
| EBITDA Margin (%) | 38.778% | 35.453% | 35.211% | 32.525% | 30.636% |
| Pre-tax Profit Margin (%) | 20.294% | 16.547% | 18.232% | 13.776% | 9.075% |
| Net Profit Margin (%) | 10.986% | 10.167% | 12.156% | 12.244% | 7.243% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 0.975 X | 0.838 X | 0.664 X | 0.630 X | 0.710 X |
| Quick Ratio (X) | 0.959 X | 0.819 X | 0.647 X | 0.612 X | 0.685 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 64.746% | 71.696% | 75.979% | 80.187% | 87.050% |
| Total Debt / Total Assets (%) | 41.245% | 47.345% | 48.872% | 50.331% | 60.476% |
| Net Debt / Total Assets (%) | 17.971% | 24.503% | 31.380% | 34.562% | 43.473% |
| Total Debt / Shareholders' Funds (%) | 122.237% | 170.917% | 201.123% | 240.959% | 404.915% |
| Long Term Debt / Shareholders' Funds (%) | 82.409% | 110.382% | 120.218% | 148.637% | 247.844% |
| Net Debt / Shareholders' Funds (%) | 53.259% | 88.455% | 129.140% | 165.466% | 291.075% |
| Net Cash / (Debt) ($) | (876.683M) | (1.190B) | (1.455B) | (1.578B) | (1.972B) |
| Net Cash / (Debt) per share ($) | (0.551) | (0.749) | (0.915) | (0.993) | (1.240) |
| Total Debt / Capital Employed (%) | 65.317% | 80.205% | 91.669% | 95.257% | 109.464% |
| Interest Coverage Ratio (X) | 6.664 X | 4.777 X | 5.292 X | 3.659 X | 2.466 X |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 7.510 Day | 7.621 Day | 7.970 Day | 11.309 Day | 10.753 Day |
| Receivables Turnover (Day) | 39.830 Day | 38.911 Day | 35.259 Day | 48.059 Day | 45.825 Day |
| Payables Turnover (Day) | 20.744 Day | 20.385 Day | 20.440 Day | 27.663 Day | 25.671 Day |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 307,128 |
| %Change | 3.298% |
| EPS / (LPS) | RMB 0.190 |
| NBV Per Share (¥) | RMB 1.035 |